Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016:2016:2902351.
doi: 10.1155/2016/2902351. Epub 2016 Jul 31.

An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes Mellitus

Affiliations
Review

An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes Mellitus

Ahlke Heydemann. J Diabetes Res. 2016.

Abstract

Type 2 diabetes mellitus (T2DM) is a worldwide epidemic, which by all predictions will only increase. To help in combating the devastating array of phenotypes associated with T2DM a highly reproducible and human disease-similar mouse model is required for researchers. The current options are genetic manipulations to cause T2DM symptoms or diet induced obesity and T2DM symptoms. These methods to model human T2DM have their benefits and their detractions. As far as modeling the majority of T2DM cases, HFD establishes the proper etiological, pathological, and treatment options. A limitation of HFD is that it requires months of feeding to achieve the full spectrum of T2DM symptoms and no standard protocol has been established. This paper will attempt to rectify the last limitation and argue for a standard group of HFD protocols and standard analysis procedures.

PubMed Disclaimer

Figures

Figure 1
Figure 1
An illustration of the positive feedback nature of type 2 diabetes mellitus and murine high fat diet. Both humans and mice continue around this circle at an increasing level of pathology until they acquire one or more of the irreversible disease outcomes at the bottom of the illustration.

Similar articles

Cited by

References

    1. Reaven G. M. The insulin resistance syndrome: definition and dietary approaches to treatment. Annual Review of Nutrition. 2005;25:391–406. doi: 10.1146/annurev.nutr.24.012003.132155. - DOI - PubMed
    1. Katunga L. A., Gudimella P., Efird J. T., et al. Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy. Molecular Metabolism. 2015;4(6):493–506. doi: 10.1016/j.molmet.2015.04.001. - DOI - PMC - PubMed
    1. Raz I., Eldor R., Cernea S., Shafrir E. Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes/Metabolism Research and Reviews. 2005;21(1):3–14. doi: 10.1002/dmrr.493. - DOI - PubMed
    1. Baribault H. Mouse models of type II diabetes mellitus in drug discovery. Methods in Molecular Biology. 2010;602:135–155. doi: 10.1007/978-1-60761-058-8_9. - DOI - PubMed
    1. Fuentes-Antras J., Picatoste B., Gomez-Hernandez A., Egido J., Tunon J., Lorenzo O. Updating experimental models of diabetic cardiomyopathy. Journal of Diabetes Research. 2015;2015:15. doi: 10.1155/2015/656795.656795 - DOI - PMC - PubMed